Nuclear p120-catenin controls the anchorage-independent upregulation of Wnt11 by repressing Kaiso-mediated transcription, thereby promoting RhoA activation [167].α-catenin inhibits tumor progression [168], and is downregulated in BC with a more metastatic phenotype [169]. This evidence concerns the gene CTNND1 and breast cancer.